Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility

The new injectable facility of Eugia Steriles Private Limited (a 100% subsidiary of Eugia Pharma Specialities Limited and a stepdown subsidiary of the Company), situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, has recently started the commercial operations.

The United States Food and Drug Administration (US FDA) inspected the above-mentioned facility from March 28, 2024 to April 05, 2024. The inspection closed with 3 observations. The observations are procedural in nature and will be responded to within the stipulated time.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1123.75 as compared to the previous close of Rs. 1123.95. The total number of shares traded during the day was 95056 in over 2003 trades.

The stock hit an intraday high of Rs. 1141.75 and intraday low of 1120.70. The net turnover during the day was Rs. 107369073.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 EugiaSteriles NewInjectableFacility USFDA Inspection 3Observations